HDC to Partner with Saint Vincent Pancreatic Cancer Center | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Savannah, Ga.-based molecular diagnostics company Health Discovery Corporation today announced that it has entered into a collaboration with a New York pancreatic cancer center to find biomarkers for the disease.

Under the exclusive agreement, HDC and the Pancreas, Biliary, and Liver Surgery Center at Saint Vincent Catholic Medical Centers in New York will work together to develop molecular diagnostics for detecting pancreatic cancer early.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.